Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Lacosamide Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco L0291ML
Description
A Certified Spiking Solution™ suitable for use in LC/MS or GC/MS applications in clinical toxicology, forensic analysis, urine drug testing, prescription monitoring or pharmaceutical research. Lacosamide is a new antiepileptic drug developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™.
Specifications
| 75-05-8 , 175481-36-4 | |
| MFCD08272557 | |
| 1.0 mg/mL in acetonitrile | |
| Ampule |
| C13H18N2O3 | |
| UN 1648 3 / PGII | |
| 250.29 | |
| 1 mL |
Safety and Handling
Recommended Storage : -20°C
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
CERILLIANT is a registered trademark of Cerilliant Corporation